. Author manuscript; available in PMC: 2018 Apr 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2017 Jan 10;23(4):648–653. doi: 10.1016/j.bbmt.2017.01.068

Table 3.

Transplant Outcomes

	UD (CI 95%)	RD (CI 95%)	Haplo (CI 95%)	p
Neutrophil Engraftment at Day 30	91 (81 – 100)	91 (80 – 100)	83 (67 –99)	0.07
Platelet Engraftment at Day 100	84 (72 – 96)	84 (71 – 97)	75 (57 – 93)	0.20
Full Donor Chimerism at Day 30	65	76	71	0.49
Graft Failure at 1 year	2	0	4	1.00
CMV Reactivation at 1 year	60 (42 – 78)	43 (21 – 65)	63 (40 – 86)	0.40
Acute GvHD (Grades 2–4)	57 (41 – 73)	36 (18 – 54)	58 (36 – 80)	0.11
Acute GvHD (Grades 3–4)	30 (17 – 43)	23 (8 – 38)	28 (8 – 48)	0.74
Chronic GvHD at 1 year	20 (8 – 32)	17 (3 – 31)	13 (0 – 26)	0.73
Severe Chronic GvHD at 1 year	15 (4 – 26)	10 (0 – 20)	10 (0 – 24)	0.61

Abbreviations: UD = Unrelated Donor; RD = Related Donor; Haplo = haploidentical; CI = Cumulative Incidence